Edition:
United Kingdom

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

12.96USD
25 Apr 2018
Change (% chg)

$0.38 (+3.02%)
Prev Close
$12.58
Open
$12.55
Day's High
$13.08
Day's Low
$12.35
Volume
23,409
Avg. Vol
36,576
52-wk High
$16.85
52-wk Low
$10.03

Chart for

About

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme,... (more)

Overall

Beta: --
Market Cap(Mil.): $332.96
Shares Outstanding(Mil.): 23.46
Dividend: --
Yield (%): --

Financials

  AQXP.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -1.88 -- --
ROI: -38.16 14.84 14.38
ROE: -38.28 16.34 16.07

BRIEF-Aquinox Provides Enrollment Update For Leadership 301 Clinical Trial Of Rosiptor

* AQUINOX PROVIDES ENROLLMENT UPDATE FOR LEADERSHIP 301 CLINICAL TRIAL OF ROSIPTOR

09 Feb 2018

BRIEF-‍Aquinox Statement On Fda Advisory Committee Meeting To Discuss Interstitial Cystitis/Bladder Pain Syndrome​

* ‍AQUINOX STATEMENT ON FDA ADVISORY COMMITTEE MEETING TO DISCUSS INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME​

08 Dec 2017

BRIEF-Aquinox Pharmaceuticals qtrly ‍net loss per share $0.50​

* Aquinox Pharmaceuticals announces third quarter 2017 financial results

08 Nov 2017

Earnings vs. Estimates